MedTrace Logo

Validation of Different Risk Assessment Strategies in Normotensive Pulmonary Embolism

NCT02843243 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2021-07-22

No results posted yet for this study

Summary

A risk stratification in hemodynamically stable patients with acute pulmonary embolism (PE) is deemed necessary to guide patient management. With the aim to improve the positive predictive value (PPV) for PE-related adverse events in in normotensive patients, a number of scores combining multiple risk-factors have been published. In addition, an algorithm for the risk-stratification of patients with PE has been proposed by the European society of cardiology. None but one of these scores underwent external and prospective validation. The aim of this study is to externally and prospectively validate the PPV for PE-related adverse events of the Bova score and modified FAST score in a large multicenter cohort.

Conditions

Sponsors & Collaborators

  • Azienda Ospedaliera Cosenza

    lead OTHER

Principal Investigators

  • Carlo Bova, MD · Azienda Ospedaliera Cosenza

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2019-03-31
Completion
2019-03-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02843243 on ClinicalTrials.gov